Stacey Kloiber

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

Robert Spiera, Jessica Gordon, Jamie Mersten et al. · Annals of the Rheumatic Diseases · 2011 · 174 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

Christine G. Lee, Brandy M. Heckman‐Stoddard, Dana Dabelea et al. · Diabetes Care · 2021 · 99 citations · Full text

Medicine, Pharmacotherapy, Preventive Medicine +17

The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures

Andrea M. Kriska, Bonny Rockette‐Wagner, Sharon L. Edelstein et al. · Diabetes Care · 2020 · 72 citations · Full text

Medicine, Health Promotion, Preventive Medicine +16

Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience

Neil H. White, Qing Pan, William C. Knowler et al. · Diabetes Care · 2022 · 31 citations · Full text

Medicine, Internal Medicine, Ophthalmology +17

Association of Metformin With the Development of Age-Related Macular Degeneration

Amitha Domalpally, Samuel A. Whittier, Qing Pan et al. · JAMA Ophthalmology · 2022 · 25 citations · Full text

Health Professions, Geriatric Medicine, Ophthalmology +14